Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.
第一作者:
Elena,Castro
第一单位:
Spanish National Cancer Research Centre 3, Melchor Fernández Almagro, Madrid, Spain.
作者:
医学主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤药, 激素(Antineoplastic Agents, Hormonal);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);BRCA1蛋白质(BRCA1 Protein);BRCA2蛋白质(BRCA2 Protein);近距离放射疗法(Brachytherapy);随访研究(Follow-Up Studies);疾病遗传易感性(Genetic Predisposition to Disease);生殖细胞系突变(Germ-Line Mutation);杂合子(Heterozygote);人类(Humans);Kaplan-Meiers评估(Kaplan-Meier Estimate);淋巴结(Lymph Nodes);淋巴转移(Lymphatic Metastasis);男(雄)性(Male);中年人(Middle Aged);肿瘤分期(Neoplasm Staging);列线图(Nomograms);姑息疗法(Palliative Care);表型(Phenotype);试验预期值(Predictive Value of Tests);预后(Prognosis);比例危险度模型(Proportional Hazards Models);前列腺切除术(Prostatectomy);前列腺肿瘤(Prostatic Neoplasms);放射疗法, 辅助(Radiotherapy, Adjuvant);回顾性研究(Retrospective Studies);危险性评估(Risk Assessment);危险因素(Risk Factors)
DOI
10.1200/JCO.2012.43.1882
PMID
23569316
发布时间
2025-05-29
- 浏览46
Journal of clinical oncology
1748-57页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



